お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、黄熱病ワクチンの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に黄熱病ワクチン市場を分類しています。
本レポートでは世界の黄熱病ワクチン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Sanofi Pasteur、Bio-Manguinhos、FSUE Chumakov、Institut Pasteur de Dakar

レポートは黄熱病ワクチンの主要生産者を調査し、主要地域や国の消費状況も提供します。黄熱病ワクチンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Institonal Contributions
    Private Purchase
    Others

用途別の市場セグメント：
    Routine Immunization
    Travelers
    Other

本レポートの詳細内容
本レポートは、世界の黄熱病ワクチン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて黄熱病ワクチン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の黄熱病ワクチン生産量、成長率、市場シェアを調査している。

二. 消費面では、黄熱病ワクチンの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの黄熱病ワクチン売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の黄熱病ワクチン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本黄熱病ワクチンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：黄熱病ワクチンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 黄熱病ワクチンの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける黄熱病ワクチンの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章黄熱病ワクチンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：黄熱病ワクチンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：黄熱病ワクチンの主要メーカーの概要を提供し、製品の説明と仕様、黄熱病ワクチンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：黄熱病ワクチンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Yellow fever vaccine is a vaccine that can prevent yellow fever. The vaccination targets are people who enter or pass through the epidemic area.
The global Yellow Fever Vaccines market is projected to grow from US$ 134.9 million in 2024 to US$ 172.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
Global Yellow Fever Vaccines key players include Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, etc. Global top three manufacturers hold a share about 90%.
Middle East and Africa is the largest market, with a share about 70%, followed by South America, and Europe, both have a share about 30 percent. 
In terms of application, the largest application is Routine Immunization, followed by Travelers.

Report Covers:
This report presents an overview of global market for Yellow Fever Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Yellow Fever Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Yellow Fever Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Yellow Fever Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Yellow Fever Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Distribution Channel, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Yellow Fever Vaccines sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Sanofi Pasteur
    Bio-Manguinhos
    FSUE Chumakov
    Institut Pasteur de Dakar

Segment by Distribution Channel
    Institonal Contributions
    Private Purchase
    Others

Segment by Application
    Routine Immunization
    Travelers
    Other

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Distribution Channel, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Yellow Fever Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Yellow Fever Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Distribution Channel, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Distribution Channel, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Distribution Channel, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Distribution Channel, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Distribution Channel, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Distribution Channel, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Yellow Fever Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Yellow Fever Vaccines Market Size Growth Rate by Distribution Channel, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Institonal Contributions
    Table 3. Major Manufacturers of Private Purchase
    Table 4. Major Manufacturers of Others
    Table 5. Global Yellow Fever Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Yellow Fever Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Yellow Fever Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Yellow Fever Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Yellow Fever Vaccines Revenue Market Share by Region (2019-2024)
    Table 10. Global Yellow Fever Vaccines Revenue Market Share by Region (2025-2030)
    Table 11. Global Yellow Fever Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Yellow Fever Vaccines Sales by Region (2019-2024) & (K Units)
    Table 13. Global Yellow Fever Vaccines Sales by Region (2025-2030) & (K Units)
    Table 14. Global Yellow Fever Vaccines Sales Market Share by Region (2019-2024)
    Table 15. Global Yellow Fever Vaccines Sales Market Share by Region (2025-2030)
    Table 16. Global Yellow Fever Vaccines Sales by Manufacturers (2019-2024) & (K Units)
    Table 17. Global Yellow Fever Vaccines Sales Share by Manufacturers (2019-2024)
    Table 18. Global Yellow Fever Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Yellow Fever Vaccines Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Yellow Fever Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Yellow Fever Vaccines Price by Manufacturers 2019-2024 (US$/Unit)
    Table 22. Global Yellow Fever Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Yellow Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Yellow Fever Vaccines as of 2023)
    Table 24. Global Key Manufacturers of Yellow Fever Vaccines, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Yellow Fever Vaccines, Product Offered and Application
    Table 26. Global Key Manufacturers of Yellow Fever Vaccines, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Yellow Fever Vaccines Sales by Distribution Channel (2019-2024) & (K Units)
    Table 29. Global Yellow Fever Vaccines Sales by Distribution Channel (2025-2030) & (K Units)
    Table 30. Global Yellow Fever Vaccines Sales Share by Distribution Channel (2019-2024)
    Table 31. Global Yellow Fever Vaccines Sales Share by Distribution Channel (2025-2030)
    Table 32. Global Yellow Fever Vaccines Revenue by Distribution Channel (2019-2024) & (US$ Million)
    Table 33. Global Yellow Fever Vaccines Revenue by Distribution Channel (2025-2030) & (US$ Million)
    Table 34. Global Yellow Fever Vaccines Revenue Share by Distribution Channel (2019-2024)
    Table 35. Global Yellow Fever Vaccines Revenue Share by Distribution Channel (2025-2030)
    Table 36. Yellow Fever Vaccines Price by Distribution Channel (2019-2024) & (US$/Unit)
    Table 37. Global Yellow Fever Vaccines Price Forecast by Distribution Channel (2025-2030) & (US$/Unit)
    Table 38. Global Yellow Fever Vaccines Sales by Application (2019-2024) & (K Units)
    Table 39. Global Yellow Fever Vaccines Sales by Application (2025-2030) & (K Units)
    Table 40. Global Yellow Fever Vaccines Sales Share by Application (2019-2024)
    Table 41. Global Yellow Fever Vaccines Sales Share by Application (2025-2030)
    Table 42. Global Yellow Fever Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Yellow Fever Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Yellow Fever Vaccines Revenue Share by Application (2019-2024)
    Table 45. Global Yellow Fever Vaccines Revenue Share by Application (2025-2030)
    Table 46. Yellow Fever Vaccines Price by Application (2019-2024) & (US$/Unit)
    Table 47. Global Yellow Fever Vaccines Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 48. US & Canada Yellow Fever Vaccines Sales by Distribution Channel (2019-2024) & (K Units)
    Table 49. US & Canada Yellow Fever Vaccines Sales by Distribution Channel (2025-2030) & (K Units)
    Table 50. US & Canada Yellow Fever Vaccines Revenue by Distribution Channel (2019-2024) & (US$ Million)
    Table 51. US & Canada Yellow Fever Vaccines Revenue by Distribution Channel (2025-2030) & (US$ Million)
    Table 52. US & Canada Yellow Fever Vaccines Sales by Application (2019-2024) & (K Units)
    Table 53. US & Canada Yellow Fever Vaccines Sales by Application (2025-2030) & (K Units)
    Table 54. US & Canada Yellow Fever Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Yellow Fever Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Yellow Fever Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Yellow Fever Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Yellow Fever Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Yellow Fever Vaccines Sales by Country (2019-2024) & (K Units)
    Table 60. US & Canada Yellow Fever Vaccines Sales by Country (2025-2030) & (K Units)
    Table 61. Europe Yellow Fever Vaccines Sales by Distribution Channel (2019-2024) & (K Units)
    Table 62. Europe Yellow Fever Vaccines Sales by Distribution Channel (2025-2030) & (K Units)
    Table 63. Europe Yellow Fever Vaccines Revenue by Distribution Channel (2019-2024) & (US$ Million)
    Table 64. Europe Yellow Fever Vaccines Revenue by Distribution Channel (2025-2030) & (US$ Million)
    Table 65. Europe Yellow Fever Vaccines Sales by Application (2019-2024) & (K Units)
    Table 66. Europe Yellow Fever Vaccines Sales by Application (2025-2030) & (K Units)
    Table 67. Europe Yellow Fever Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Yellow Fever Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Yellow Fever Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Yellow Fever Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Yellow Fever Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Yellow Fever Vaccines Sales by Country (2019-2024) & (K Units)
    Table 73. Europe Yellow Fever Vaccines Sales by Country (2025-2030) & (K Units)
    Table 74. China Yellow Fever Vaccines Sales by Distribution Channel (2019-2024) & (K Units)
    Table 75. China Yellow Fever Vaccines Sales by Distribution Channel (2025-2030) & (K Units)
    Table 76. China Yellow Fever Vaccines Revenue by Distribution Channel (2019-2024) & (US$ Million)
    Table 77. China Yellow Fever Vaccines Revenue by Distribution Channel (2025-2030) & (US$ Million)
    Table 78. China Yellow Fever Vaccines Sales by Application (2019-2024) & (K Units)
    Table 79. China Yellow Fever Vaccines Sales by Application (2025-2030) & (K Units)
    Table 80. China Yellow Fever Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Yellow Fever Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Yellow Fever Vaccines Sales by Distribution Channel (2019-2024) & (K Units)
    Table 83. Asia Yellow Fever Vaccines Sales by Distribution Channel (2025-2030) & (K Units)
    Table 84. Asia Yellow Fever Vaccines Revenue by Distribution Channel (2019-2024) & (US$ Million)
    Table 85. Asia Yellow Fever Vaccines Revenue by Distribution Channel (2025-2030) & (US$ Million)
    Table 86. Asia Yellow Fever Vaccines Sales by Application (2019-2024) & (K Units)
    Table 87. Asia Yellow Fever Vaccines Sales by Application (2025-2030) & (K Units)
    Table 88. Asia Yellow Fever Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Yellow Fever Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Yellow Fever Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Yellow Fever Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Yellow Fever Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Yellow Fever Vaccines Sales by Region (2019-2024) & (K Units)
    Table 94. Asia Yellow Fever Vaccines Sales by Region (2025-2030) & (K Units)
    Table 95. Middle East, Africa and Latin America Yellow Fever Vaccines Sales by Distribution Channel (2019-2024) & (K Units)
    Table 96. Middle East, Africa and Latin America Yellow Fever Vaccines Sales by Distribution Channel (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue by Distribution Channel (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue by Distribution Channel (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Yellow Fever Vaccines Sales by Application (2019-2024) & (K Units)
    Table 100. Middle East, Africa and Latin America Yellow Fever Vaccines Sales by Application (2025-2030) & (K Units)
    Table 101. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Yellow Fever Vaccines Sales by Country (2019-2024) & (K Units)
    Table 107. Middle East, Africa and Latin America Yellow Fever Vaccines Sales by Country (2025-2030) & (K Units)
    Table 108. Sanofi Pasteur Company Information
    Table 109. Sanofi Pasteur Description and Major Businesses
    Table 110. Sanofi Pasteur Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 111. Sanofi Pasteur Yellow Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Sanofi Pasteur Recent Developments
    Table 113. Bio-Manguinhos Company Information
    Table 114. Bio-Manguinhos Description and Major Businesses
    Table 115. Bio-Manguinhos Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 116. Bio-Manguinhos Yellow Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Bio-Manguinhos Recent Developments
    Table 118. FSUE Chumakov Company Information
    Table 119. FSUE Chumakov Description and Major Businesses
    Table 120. FSUE Chumakov Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 121. FSUE Chumakov Yellow Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. FSUE Chumakov Recent Developments
    Table 123. Institut Pasteur de Dakar Company Information
    Table 124. Institut Pasteur de Dakar Description and Major Businesses
    Table 125. Institut Pasteur de Dakar Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 126. Institut Pasteur de Dakar Yellow Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Institut Pasteur de Dakar Recent Developments
    Table 128. Key Raw Materials Lists
    Table 129. Raw Materials Key Suppliers Lists
    Table 130. Yellow Fever Vaccines Distributors List
    Table 131. Yellow Fever Vaccines Customers List
    Table 132. Yellow Fever Vaccines Market Trends
    Table 133. Yellow Fever Vaccines Market Drivers
    Table 134. Yellow Fever Vaccines Market Challenges
    Table 135. Yellow Fever Vaccines Market Restraints
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Yellow Fever Vaccines Product Picture
    Figure 2. Global Yellow Fever Vaccines Market Size Growth Rate by Distribution Channel, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Yellow Fever Vaccines Market Share by Distribution Channel in 2023 & 2030
    Figure 4. Institonal Contributions Product Picture
    Figure 5. Private Purchase Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Yellow Fever Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Yellow Fever Vaccines Market Share by Application in 2023 & 2030
    Figure 9. Routine Immunization
    Figure 10. Travelers
    Figure 11. Other
    Figure 12. Yellow Fever Vaccines Report Years Considered
    Figure 13. Global Yellow Fever Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Yellow Fever Vaccines Revenue 2019-2030 (US$ Million)
    Figure 15. Global Yellow Fever Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Yellow Fever Vaccines Revenue Market Share by Region (2019-2030)
    Figure 17. Global Yellow Fever Vaccines Sales 2019-2030 ((K Units)
    Figure 18. Global Yellow Fever Vaccines Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Yellow Fever Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 20. US & Canada Yellow Fever Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Yellow Fever Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 22. Europe Yellow Fever Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Yellow Fever Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 24. China Yellow Fever Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Yellow Fever Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 26. Asia (excluding China) Yellow Fever Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Yellow Fever Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 28. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Yellow Fever Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Yellow Fever Vaccines in the World: Market Share by Yellow Fever Vaccines Revenue in 2023
    Figure 31. Global Yellow Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Yellow Fever Vaccines Sales Market Share by Distribution Channel (2019-2030)
    Figure 33. Global Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2019-2030)
    Figure 34. Global Yellow Fever Vaccines Sales Market Share by Application (2019-2030)
    Figure 35. Global Yellow Fever Vaccines Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Yellow Fever Vaccines Sales Market Share by Distribution Channel (2019-2030)
    Figure 37. US & Canada Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2019-2030)
    Figure 38. US & Canada Yellow Fever Vaccines Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Yellow Fever Vaccines Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Yellow Fever Vaccines Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Yellow Fever Vaccines Sales Share by Country (2019-2030)
    Figure 42. U.S. Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Yellow Fever Vaccines Sales Market Share by Distribution Channel (2019-2030)
    Figure 45. Europe Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2019-2030)
    Figure 46. Europe Yellow Fever Vaccines Sales Market Share by Application (2019-2030)
    Figure 47. Europe Yellow Fever Vaccines Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Yellow Fever Vaccines Revenue Share by Country (2019-2030)
    Figure 49. Europe Yellow Fever Vaccines Sales Share by Country (2019-2030)
    Figure 50. Germany Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 51. France Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 55. China Yellow Fever Vaccines Sales Market Share by Distribution Channel (2019-2030)
    Figure 56. China Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2019-2030)
    Figure 57. China Yellow Fever Vaccines Sales Market Share by Application (2019-2030)
    Figure 58. China Yellow Fever Vaccines Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Yellow Fever Vaccines Sales Market Share by Distribution Channel (2019-2030)
    Figure 60. Asia Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2019-2030)
    Figure 61. Asia Yellow Fever Vaccines Sales Market Share by Application (2019-2030)
    Figure 62. Asia Yellow Fever Vaccines Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Yellow Fever Vaccines Revenue Share by Region (2019-2030)
    Figure 64. Asia Yellow Fever Vaccines Sales Share by Region (2019-2030)
    Figure 65. Japan Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 69. India Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Yellow Fever Vaccines Sales Market Share by Distribution Channel (2019-2030)
    Figure 71. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2019-2030)
    Figure 72. Middle East, Africa and Latin America Yellow Fever Vaccines Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Yellow Fever Vaccines Sales Share by Country (2019-2030)
    Figure 76. Brazil Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Yellow Fever Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 81. Yellow Fever Vaccines Value Chain
    Figure 82. Yellow Fever Vaccines Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed